About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Houston | 132 Studies

Clinical Trials SchizophreniaHouston

Schizophrenia Clinical Trials in Houston

Find 132 clinical trials for schizophrenia near Houston, Texas. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 132 trials

CompletedThe Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)This study will test the usefulness of the medication metformin in treating people with schizophrenia or schizoaffective disorder who are overweight and also taking antipsychotic…NCT00816907·Palo Alto, California and 15 others CompletedA United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCorlux (mifepristone) is a new medication that modulates the body's use of a hormone called cortisol.NCT00128479·Little Rock, Arkansas and 43 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of Cariprazine in Patients With Chronic Stable SchizophreniaThis is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.NCT00839852·Costa Mesa, California and 64 others

CompletedStudy Evaluating Vabicaserin in Subjects With SchizophreniaThe primary purpose of this protocol is to establish the efficacy, safety, and tolerability of vabicaserin (SCA-136) using a once a day capsule in subjects with acute…NCT00563706·Little Rock, Arkansas and 32 others

CompletedA Comparison of Seroquel vs. Risperidone in SchizophreniaThe purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.NCT00034905·Birmingham, Alabama and 63 others

CompletedEfficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaThis is an efficacy and safety study evaluating an experimental treatment for cognitive deficits in adults with schizophrenia.NCT01077700·Anaheim, California and 23 others

TerminatedA Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaThe primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.NCT05443724·Phoenix, Arizona and 84 others

CompletedThe Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderOlanzapine is currently marketed for the treatment of schizophrenia and acute manic episodes with bipolar 1 disorder.NCT00044187·El Centro, California and 15 others

CompletedA Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)This study will evaluate weight gain of ALKS 3831 compared to olanzapine in adult subjects with schizophrenia.NCT02694328·Little Rock, Arkansas and 53 others

CompletedA Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaThe primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 3831 in subjects with schizophrenia.NCT02873208·Little Rock, Arkansas and 44 others

CompletedAn Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of SchizophreniaThis study aims to evaluate whether PF-02545920 is safe and effective in the treatment of acute exacerbation of schizophrenia during a 4-week inpatient treatment period.NCT01175135·Little Rock, Arkansas and 45 others

CompletedA Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderThis Phase IV, randomized, parallel-group study is designed to evaluate the cataractogenic potential of quetiapine fumarate (SEROQUEL) compared with that of a putative…NCT00206102·Little Rock, Arkansas and 62 others

CompletedPeer Approaches to Substances in Early Psychosis Programs: A Pilot Study of a Peer-Led InterventionThe aim of the study is to pilot a peer-provided, manualized intervention to increase the proportion of young people with first episode psychosis who reduce or stop substance use…NCT04517279·Austin, Texas and 14 others

CompletedAripiprazole in Adolescents With SchizophreniaThe purpose of this trial is to test the safety and efficacy of aripiprazole in adolescent patients with schizophrenia for a period of at least 6 weeks.NCT00102063·Birmingham, Alabama and 54 others

CompletedSystematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.NCT00012558·Stanford, California and 10 others

CompletedA Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsThe purpose of this study is to compare the efficacy and safety of ziprasidone and aripiprazole in hospitalized patients with schizophrenia or schizoaffective disorderNCT00634348·Anaheim, California and 40 others

TerminatedStudy to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaStudy to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.NCT05182476·Phoenix, Arizona and 48 others

RecruitingA Long-Term Open-Label Study of ML-007C-MA in Adults With SchizophreniaML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants with schizophrenia who have…NCT07459647·Little Rock, Arkansas and 44 others

CompletedSafety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of SchizophreniaThis is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188) relative to placebo in adult patients (18-60 years of age) with acute exacerbation of…NCT00694707·Costa Mesa, California and 64 others

Terminated20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsThe purpose of this study is to evaluate the effect of AMG 747 on negative symptoms of schizophrenia in patients who are stable on current antipsychotic treatment.NCT01568216·Anaheim, California and 37 others

PreviousPage 4 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia